Publications

Clewell HJ, Gearhart JM, Gentry PR, Covington TR, Van Landingham CB, Crump KS, and Shipp AM. 1999. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal 19(4):541–552; doi: 10.1111/j.1539-6924.1999.tb00427.x.

Rish W, Kirman CR, Hays SM, Gargas ML, Andersen ME, Reitz RH, Guengerich FP, Green T, McConnell EE, Buckpit A, Voytek P, Dugard PH. 1999. Developing a physiologically based pharmacokinetic model to describe methylene chloride kinetics at the subcellular level. Toxicologist 48, Paper No. 671. Presented at Society of Toxicology 38th Annual Meeting, New Orleans, LA, March 1999.

Cyr PL, Malloy D. 1999. Patient satisfaction and physician profiling. In: Lynman K, Piland N (eds) Physician Profiling: A Source Book for Health Care Administrators. Jossey-Bass Health Series, San Francisco. pp. 121-136.

Trippodo NC, Fox M, Monticello TM, Panchal BC, Asaad MM. 1999. Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril. J Cardiovasc Pharmacol 34(6):782-790; doi: 10.1097/00005344-199912000-00003.

Casale RA, Jensen IS, Egholm M. 1999. Synthesis of PNA oligomers by Fmoc chemistry. In Peptide Nucleic Acids: Protocols & Applications. Weymondham, UK: Horizon Scientific Press.

McNamara JF, Lombardo H, Pillai SK, Jensen IS, Kates SA. A comparison of solid-phase techniques for the construction of chemokines. In Bajusz S, Hudecz F (eds), Peptides 1998: Proceedings of the Twenty-Fifth European Peptide Symposium 30 August–4 September 1998, Budapest. Mayflower Worldwide Limited, Birmingham, England, 1999.

Segal BM, McNamara JF, Jensen IS, Kates SA, Holm RH. Design and synthesis of cyclic peptides for iron-sulfur cluster assembly and encapsulation. In: Bajusz S, Hudecz F (eds), Peptides 1998: Proceedings of the Twenty-Fifth European Peptide Symposium 30 August–4 September 1998, Budapest. Mayflower Worldwide Limited, Birmingham, England, 1999.

Zucker RM, Hunter ES III, Rogers JM. 1999. Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods 18(4):473–480; doi: 10.1006/meth.1999.0815.

Parvathy S, Choksi N, Fang Y, Sabo SL, Buxbaum JD. Characterization of multipartite complexes of APP. Poster presented at Society for Neuroscience Annual Meeting, 1999

Lilliehook C, Choksi NY, Hof P, Choi EK, Zaidi NF, Wasco W, et al. Characterization of the presenilin-binding protein calsenilin. Poster presented at Society for Neuroscience Annual Meeting, 1999

Fang Y, Choksi NY, Parvathy S, Yamin JJ, Wasco W, Buxbaum JD. Proteins interacting with the COOH-termini of the presenilins. Poster presented at Society for Neuroscience Annual Meeting, 1999.

Choksi NY, Mukherjeree P, Lindroth A, Xiang Z, Wasco W, Buxbaum JD, Pasinetti GM. Cyclooxygenase (COX)-2 expression is associated with presenilin-2 induced apoptosis. Poster presented at Society for Neuroscience Annual Meeting, 1999.

Gentry R, Clewell H, Gearhart J, Covington T, Andersen M. Development of a physiologically-based pharmacokinetic (PB-PK) model for isopropanol and acetone. Poster presented at  Society of Toxicology 38th Annual Meeting, New Orleans, LA, March 1999.

Kodavanti PR, Derr-Yellin EC, Mundy WR, Shafer TJ, Herr DW Barone S, Choksi NY, MacPhail RC, Tilson HA. 1998. Repeated exposure of Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase. Toxicol Appl Pharmacol 153:186–198; doi: 10.1006/taap.1998.8533.

Gerhardt B, Kordas TJ, Thompson CM, Patel P, Vida TV. 1998. The vesicle transport protein, Vps33p, is an ATP binding protein that localizes to the cytosol in an energy dependent manner. J Biol Chem 273(25):15818–15829; doi: 10.1074/jbc.273.25.15818.

Fraiser LH, Tachovsky JA, King ME, McCoy JT, Haws LC. Hazardous waste combustion risk assessment experience in the state of Texas. International Conference on Incineration and Thermal Treatment Technologies Conference, Salt Lake City, UT, May 1998.

Thompson CM, Kawashima H, and Strobel HW. 1998. Isolation of partially purified P450 2D18 and characterization of activity towards the tricyclic antidepressants imipramine and desipramine. Arch Biochem Biophys 359(1):115–121; doi: 10.1006/abbi.1998.0892.

Jensen IS, McNamara JF, Lombardo H, Pillai SK, Kates SA. Solid-phase assembly of chemokines: A survey of synthetic approaches to RANTES. Twelfth Symposium of the Protein Society. San Diego, CA, July 1998.

Rogers JM. 1997. Life stage and its impact on risk of environmentally-induced adverse effects: Introduction. Environ Toxicol Pharmacol 4(3-4):299–300; doi: 10.1016/s1382-6689(97)10027-8.

Casale RA, Paul CH, Jensen IS, Moyer ML, Kates SA, Egholm M. 1998. A comparison of solid supports for PNA synthesis. In Epton R (ed), Innovation and Perspectives in Solid Phase Synthesis and Combinatorial Libraries. Birmingham, England: Mayflower Worldwide Limited.